Physician profile
Aatish Garg
NPI 1245595149
$16,098.34
in general payments reported to CMS, 2019-2025
14 companies · $998 in 2025
The $998 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,372 · 2020: $3,603 · 2021: $1,241 · 2022: $2,027 · 2023: $1,683 · 2024: $2,176 · 2025: $998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,654 · Travel and Lodging: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,653.56 |
| Travel and Lodging | $1,202.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,938.89 | 2019-2025 | Watchman Flx, Farapulse, General - Therapies |
| Abbott Laboratories | $4,030.56 | 2021-2025 | Aveir, Ensite, Viewmate |
| Medical Device Business Services, INC. | $1,955.78 | 2019-2020 | |
| Medtronic, INC. | $810.63 | 2021-2025 | Linq II, Micra, Evera Mri Xt Dr Surescan |
| Biosense Webster, INC. | $689.03 | 2020-2025 | Qdot Micro Catheter, Nuvision Ice Catheter |
| Cardiva Medical, INC. | $131.68 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $126.58 | 2021-2023 | Camzyos |
| Impulse Dynamics (USA) INC. | $123.98 | 2022 | |
| Atricure, INC. | $120.65 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.54 | 2022-2025 | Lifevest |
| Scpharmaceuticals INC. | $33.09 | 2023-2025 | |
| Medtronic Vascular, INC. | $26.35 | 2019 | |
| Amgen INC. | $15.71 | 2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $13.87 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aatish Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.